Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

Jun Zhang1, Chong-Bo Liu, Rong-Cheng Li

  • 1National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361005, China.

Vaccine
|January 27, 2009
PubMed